SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Claud B who wrote (2883)3/20/1998 10:33:00 PM
From: Bradpalm1   of 7041
 
<<This shows your total lack of real understanding. The trials have long been finished.>>

Oh? Which trials are you talking about? Completed trials ZON 300 and ZON 301 or ongoing trials ZON 302 and ZON 303? If these last 2 open label, 12 month "safety trials" involving 2600 men were started just last September, the EARLIEST that Vasomax' NDA could be submitted is this coming October. Right, Claud? Or does SPG and Zonagen plan on submitting Vasomax' NDA in THIS country without these FDA requested studies?

Bradpalm1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext